Reduction in the level of Gal(alpha 1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase

被引:170
作者
Sharma, A
Okabe, J
Birch, P
McClellan, SB
Martin, MJ
Platt, JL
Logan, JS
机构
[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT PEDIAT,DURHAM,NC 27710
[3] DUKE UNIV,MED CTR,DEPT IMMUNOL,DURHAM,NC 27710
关键词
D O I
10.1073/pnas.93.14.7190
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hyperacute rejection of a porcine organ by higher primates is initiated by the binding of xenoreactive natural antibodies of the recipient to blood vessels in the graft leading to complement activation, The majority of these antibodies recognize the carbohydrate structure Gal(alpha 1,3)Gal (gal epitope) present on cells of pigs. It is possible that the removal or lowering of the number of gal epitopes on the graft endothelium could prevent hyperacute rejection, The Gal(alpha 1,3)Gal structure is formed by the enzyme Gal beta 1,4GlcNAc3-alpha-D-galactosyltransferase [alpha(1,3)GT; EC 2.4.1.51], which transfers a galactose molecule to terminal N-acetyllactosamine (N-lac) present on various glycoproteins and glycolipids. The N-lac structure might be utilized as an acceptor by other glycosyltransferases such as Gal beta 1,4GlcNAc 6-alpha-D-sialyltransferase [alpha(2,6)ST], Gal beta 1-4GlcNAc 3-alpha-D-sialyvltransferase [alpha(2,3)ST], or Gal beta 2-alpha-L-fucosyltransferase [alpha(1,2)FT; EC 2.4.1.69], etc. In this report we describe the competition between alpha(1,2)FT and alpha(1,3)GT in cells in culture and the generation of transgenic mice and transgenic pigs that express alpha(1,2)FT leading to synthesis of Fuc alpha 1,2Gal beta- (H antigen) and a concomittant decrease in the level of Gal(alpha 1,3)Gal. ks predicted, this resulted in reduced binding of xenoreactive natural antibodies to endothelial cells of transgenic mice and protection from complement mediated lysis.
引用
收藏
页码:7190 / 7195
页数:6
相关论文
共 34 条
[1]  
BLANKEN WM, 1985, J BIOL CHEM, V260, P2927
[2]   PROTECTION OF XENOGENEIC CARDIAC ENDOTHELIUM FROM HUMAN-COMPLEMENT BY EXPRESSION OF CD59 OR DAF IN TRANSGENIC MICE [J].
BYRNE, GW ;
MCCURRY, KR ;
KAGAN, D ;
QUINN, C ;
MARTIN, MJ ;
PLATT, JL ;
LOGAN, JS .
TRANSPLANTATION, 1995, 60 (10) :1149-1156
[3]   ISOLATION AND CHARACTERIZATION OF 6 DIFFERENT CHICKEN ACTIN GENES [J].
CHANG, KS ;
ZIMMER, WE ;
BERGSMA, DJ ;
DODGSON, JB ;
SCHWARTZ, RJ .
MOLECULAR AND CELLULAR BIOLOGY, 1984, 4 (11) :2498-2508
[4]  
Collins Braldey H., 1994, Xenotransplantation, V1, P36, DOI 10.1111/j.1399-3089.1994.tb00048.x
[5]   OLIGOSACCHARIDES AND DISCORDANT XENOTRANSPLANTATION [J].
COOPER, DKC ;
KOREN, E ;
ORIOL, R .
IMMUNOLOGICAL REVIEWS, 1994, 141 :31-58
[6]  
Cummings RD, 1994, GUIDE TECHNIQUES GLY, P66
[7]  
DALMASSO AP, 1992, AM J PATHOL, V140, P1157
[8]   EXPRESSION OF A FUNCTIONAL HUMAN-COMPLEMENT INHIBITOR IN A TRANSGENIC PIG AS A MODEL FOR THE PREVENTION OF XENOGENEIC HYPERACUTE ORGAN REJECTION [J].
FODOR, WL ;
WILLIAMS, BL ;
MATIS, LA ;
MADRI, JA ;
ROLLINS, SA ;
KNIGHT, JW ;
VELANDER, W ;
SQUINTO, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11153-11157
[9]  
GALILI U, 1988, J BIOL CHEM, V263, P17755
[10]   EVOLUTIONARY RELATIONSHIP BETWEEN THE NATURAL ANTI-GAL ANTIBODY AND THE GAL-ALPHA-1-]3GAL EPITOPE IN PRIMATES [J].
GALILI, U ;
CLARK, MR ;
SHOHET, SB ;
BUEHLER, J ;
MACHER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (05) :1369-1373